News and Opinions
World Stem Cell Summit 2018 in Miami Solidifies Regenerative Medicine as the Future of Healthcare
Miami, FL – January 30, 2017 – The international regenerative medicine community concluded a week sharing breakthroughs, facing challenges and developing collaborations at the 13th World Stem Cell Summit (WSCS) at the Hyatt Regency Miami, January 22-26, 2018. The...
Interview: Dr. Anthony Atala discusses the future of regenerative medicine
By Nick Rodriguez South Florida News Service (Photo credit: Nick Rodriguez)MIAMI-January 25, 2018 – Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine and the W.H. Boyce professor and chair of the Department of Urology at Wake...
Joe and Jill Biden among several honored at World Stem Cell Summit gala
By Jessica Barrios South Florida News Service (Photo courtesy Howard Miller) MIAMI – January 25, 2018 – Greg Simon, president of the Biden Cancer Initiative gives an acceptance speech on behalf of the Bidens. Former Vice President Joe Biden and Dr. Jill Biden were...
Longeveron to Play Prominent Role at the World Stem Cell Summit in Miami
MIAMI, Jan. 22, 2018 /PRNewswire/ -- Longeveron LLC, regenerative medicine company, announced that it will help roll out the red carpet when investigators from around the globe converge on the company's hometown of Miami for the 2018 World Stem Cell Summit, January...
Longeveron Aging Frailty Phase 2b Trial
Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only...
Longeveron Alzheimer’s Disease Trial
Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem...
Aging Frailty with Influenza Vaccine Trial announced by Longeveron
America is facing one of the worst influenza seasons in recent history. The influenza virus is one of the top ten causes of death in elderly people. Longeveron is conducting a multi-center, randomized, placebo controlled trial using its Longeveron Mesenchymal Stem...
Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit
PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D.,...
Mayo Clinic Center for Regenerative Medicine at the 2018 World Stem Cell Summit
The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the 13th annual event Jan. 22-26 in Miami, Florida. Researchers and clinical experts from Mayo Clinic will participate in...
California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients
January 18, 2018 - Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease - a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically matched, living...
Pioneers of Hope: Patient Advocate Doug Oliver’s Interview of Dr. Francis Collins, Director, National Institutes of Health (NIH)
The Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with leading influencers in the Regenerative Medicine movement. These articles are our way of sharing the hope that this...
AgeX CEO Michael D. West to Present in Plenary Session at The World Stem Cell Summit on “Stem Cell Innovations That Will Change the World”
ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), today announced that AgeX will present in a Plenary session, “Stem Cell Innovations That Will Change the World – Part 2,” at the World Stem Cell Summit...
NSU to present at World Stem Cell Summit
By Christina Mclaughlin Researchers and faculty members from NSU’s College of Allopathic Medicine (M.D. College) will present their research in the fields of cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summit from Jan. 22-26 at the Hyatt...
Society for Regenerative Medicine Manufacturing Formed – Goal is to Speed up New Treatments for Patients
Miami, Fla. – Jan. 4, 2018 -- The inaugural meeting of the newly formed Regenerative Medicine Manufacturing Society will take place on Friday, Jan. 26, in Miami during the World Stem Cell Summit. The society’s goal is to promote the scale-up of regenerative medicine...
Nova Southeastern University Researchers to Present at 2018 World Stem Cell Summit
Scientists from the NSU M.D. College will Discuss -Transformational Approaches to Cancer Immunotherapy and Regenerative Medicine FORT LAUDERDALE/DAVIE, Fla. – Leading faculty members from the Nova Southeastern University (NSU) College of Allopathic Medicine (M.D....
World Stem Cell Summit Announces Co-organizing Partners, Visionary Speakers, Agenda And Registration Details
Click Here to Register for WSCS 2018 Finding Cures Via Regenerative Medicine From January 22-26, 2018 in Miami Miami, FL – November 27, 2017 — The 13th World Stem Cell Summit (WSCS) is proud to announce that their upcoming event at the Hyatt Regency Miami, taking...
FDA, Patients, and Providers: A Brand New “Relation-shift.”
By Doug Oliver: I’m very positive about the future role of FDA in ensuring that stem cell and related therapies are safe and effective. And, because of that, I believe now is the appointed time for both patients AND therapy providers to be intentional in helping to...
Committed to Cures: An Interview with RMF’s Bernard Siegel. (courtesy of Future Medicine)
(Interview courtesy of Future Medicine) Bernard Siegel is the Founder and full-time Executive Director of the nonprofit Regenerative Medicine Foundation (FL, USA). He is the Founder and the Co-chair of the World Stem Cell Summit series of global conferences and...
Why we need to modernize Informed Consent
I just spent a week at Wake Forest University Institute for Regenerative Medicine. I enjoyed the experience of being immersed in all things tissue-regeneration, bio-printing, scaffold development, and, especially, the unique collaboration model they have with private...
New York City: a New Hub for Stem Cell Research
On December 2016, Mayor Bill De Blasio announced that the city’s next great industry is biotechnology. A lofty goal grounded in reality and backed with a $500 million funding commitment. Not long after this announcement, in April 2017, I visited New York to witness...
Join Regenerative Medicine Foundation
Join today and get access to our newsletter and exclusive updates about events
and all things happening with regenerative medicine.
Join Our Mailing List
The Regenerative Medicine Foundation is a non-profit organization, granted tax-exempt status under Section 501(c)(3) of the United States Internal Revenue Code. Contributions are tax-deductible to the extent allowable by law.
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.